Company

Verrica Pharmaceuticals, Inc.

US biopharmaceutical company developing dermatology treatments, led by YCANTH for common warts.

About

Founded in 2013 and headquartered in West Chester, US, Verrica Pharmaceuticals, Inc. develops treatments for dermatological conditions. Its flagship product, YCANTH, is designed to treat common warts. The company is led by CEO Ted White and has completed 6 deals to date. In 2024, revenue was USD 7,566,000 and EBITDA was USD -65,577,000.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in